| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/01/2023 | bioAffinity Technologies, Inc. | | Grant | Common Stock | 10.2k | $1.83 | $18.7k | | 01/01/2023 |
| 04/15/2023 | bioAffinity Technologies, Inc. | | Grant | Common Stock | 9.9k | $1.89 | $18.7k | | 01/01/2023 |
| 01/01/2023 | bioAffinity Technologies, Inc. | | Grant | Common Stock | 8.2k | $2.28 | $18.8k | | 01/01/2023 |
| 08/31/2022 | bioAffinity Technologies, Inc. | | Purchase | | 8.2k | $0.00 | $0 | | 08/31/2022 |
| 08/31/2022 | bioAffinity Technologies, Inc. | | Purchase | | 8.2k | $0.00 | $0 | | 08/31/2022 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Stock Option (right to buy) | 5k | $26.38 | $131.9k | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Stock Option (right to buy) | 5k | $33.62 | $168.1k | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Stock Option (right to buy) | 5k | $42.14 | $210.7k | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Stock Option (right to buy) | 10k | $48.75 | $487.5k | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Stock Option (right to buy) | 10k | $31.70 | $317k | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Restricted Stock Units | 30.1k | $50.00 | $1.5M | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Deferred Unit Awards/Stock Units | 22.8k | $50.00 | $1.1M | | 09/28/2012 |
| 09/28/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Disposition | Common Stock | 3.5k | $50.00 | $175k | | 09/28/2012 |
| 07/02/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Grant | Deferred Unit Award/Stock Units | 583 | $36.50 | $21.3k | | 07/02/2012 |
| 04/02/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Grant | Deferred Unit Award/Stock Units | 534 | $39.80 | $21.3k | | 04/02/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 3.5k | $37.01 | $129.5k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 800 | $37.01 | $29.6k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 600 | $37.02 | $22.2k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 500 | $37.03 | $18.5k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 100 | $37.03 | $3.7k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 700 | $37.05 | $25.9k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Sale | Common Stock | 1.3k | $37.05 | $48.2k | | 03/19/2012 |
| 03/19/2012 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Exercise | | 7.5k | $28.79 | $215.9k | | 03/19/2012 |
| 10/01/2010 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Grant | Deferred Unit Award/Stock Units | 554 | $29.38 | $16.3k | | 10/01/2010 |
| 07/01/2010 | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | Grant | Deferred Unit Award/Stock Units | 623 | $26.09 | $16.3k | | 07/01/2010 |